These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 22786591

  • 1. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
    Nolan D, Castley A, Tschochner M, James I, Qiu W, Sayer D, Christiansen FT, Witt C, Mastaglia F, Carroll W, Kermode A.
    Neurology; 2012 Aug 07; 79(6):538-46. PubMed ID: 22786591
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles.
    Cocco E, Meloni A, Murru MR, Corongiu D, Tranquilli S, Fadda E, Murru R, Schirru L, Secci MA, Costa G, Asunis I, Cuccu S, Fenu G, Lorefice L, Carboni N, Mura G, Rosatelli MC, Marrosu MG.
    PLoS One; 2012 Aug 07; 7(7):e41678. PubMed ID: 22848563
    [Abstract] [Full Text] [Related]

  • 3. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
    Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC.
    PLoS Genet; 2009 Feb 07; 5(2):e1000369. PubMed ID: 19197344
    [Abstract] [Full Text] [Related]

  • 4. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
    Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J.
    Mult Scler; 2012 Jan 07; 18(1):16-22. PubMed ID: 21816760
    [Abstract] [Full Text] [Related]

  • 5. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May 07; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 6. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, Prada A, Saenz-Cuesta M, De Juan D, Lopez de Munain A, Olascoaga J, Otaegui D.
    Mult Scler; 2012 May 07; 18(5):569-77. PubMed ID: 22127897
    [Abstract] [Full Text] [Related]

  • 7. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, Ghelman M, Taheri T, Shakoori A.
    J Neurol Sci; 2014 Oct 15; 345(1-2):92-6. PubMed ID: 25064442
    [Abstract] [Full Text] [Related]

  • 8. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.
    Apperson ML, Tian Y, Stamova B, Ander BP, Jickling GC, Agius MA, Sharp FR.
    J Neuroimmunol; 2013 Apr 15; 257(1-2):90-6. PubMed ID: 23477965
    [Abstract] [Full Text] [Related]

  • 9. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD.
    J Hum Genet; 2009 Sep 15; 54(9):547-9. PubMed ID: 19629136
    [Abstract] [Full Text] [Related]

  • 10. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M, Roshandel D, Omidnyia E, Rshaidbaghan A.
    Clin Immunol; 2011 Jun 15; 139(3):277-81. PubMed ID: 21396892
    [Abstract] [Full Text] [Related]

  • 11. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC.
    Neurology; 2009 Dec 15; 73(24):2107-11. PubMed ID: 20018638
    [Abstract] [Full Text] [Related]

  • 12. HLA associations with multiple sclerosis in Greece.
    Kouri I, Papakonstantinou S, Bempes V, Vasiliadis HS, Kyritsis AP, Pelidou SH.
    J Neurol Sci; 2011 Sep 15; 308(1-2):28-31. PubMed ID: 21741664
    [Abstract] [Full Text] [Related]

  • 13. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
    Wagner M, Wiśniewski A, Bilińska M, Pokryszko-Dragan A, Nowak I, Kuśnierczyk P, Jasek M.
    J Neuroimmunol; 2013 May 15; 258(1-2):71-6. PubMed ID: 23507476
    [Abstract] [Full Text] [Related]

  • 14. Comment: the HLA region in multiple sclerosis.
    Goris A.
    Neurology; 2012 Aug 07; 79(6):544. PubMed ID: 22786602
    [No Abstract] [Full Text] [Related]

  • 15. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 16. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Sep 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 17. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
    Rojana-udomsart A, James I, Castley A, Needham M, Scott A, Day T, Kiers L, Corbett A, Sue C, Witt C, Martinez P, Christiansen F, Mastaglia F.
    J Neuroimmunol; 2012 Sep 15; 250(1-2):77-82. PubMed ID: 22633068
    [Abstract] [Full Text] [Related]

  • 18. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR.
    Genes Immun; 2011 Apr 15; 12(3):183-90. PubMed ID: 21179117
    [Abstract] [Full Text] [Related]

  • 19. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 20. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.